Seaport Global Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $882K | Hold |
839
| – | – | 2.79% | 10 |
|
|
2024
Q2 | $882K | Buy |
839
+328
| +64% | +$345K | 3.16% | 8 |
|
|
2024
Q1 | $492K | Buy |
+511
| New | +$492K | 1% | 43 |
|
|
2023
Q4 | – | Sell |
-251
| Closed | -$207K | – | 90 |
|
|
2023
Q3 | $207K | Sell |
251
-478
| -66% | -$393K | 0.62% | 58 |
|
|
2023
Q2 | $524K | Buy |
729
+115
| +19% | +$82.6K | 1.54% | 18 |
|
|
2023
Q1 | $505K | Buy |
614
+136
| +28% | +$112K | 1.59% | 15 |
|
|
2022
Q4 | $345K | Hold |
478
| – | – | 1.2% | 27 |
|
|
2022
Q3 | $329K | Buy |
478
+32
| +7% | +$22K | 1.34% | 16 |
|
|
2022
Q2 | $264K | Sell |
446
-61
| -12% | -$36.1K | 0.98% | 35 |
|
|
2022
Q1 | $354K | Sell |
507
-1,087
| -68% | -$759K | 1.13% | 32 |
|
|
2021
Q4 | $1.01M | Buy |
+1,594
| New | +$1.01M | 1.36% | 28 |
|